Scott M. White

Biography

 SCOTT M. WHITE joined Inovio Pharmaceuticals as Vice President, Clinical Development in February 2015 where he has responsibility for the clinical development of the infectious diseases portfolio. Prior to joining Inovio he was a Senior Director with GlaxoSmithKline where he had led the worldwide clinical development of several products spanning antibacterial, antiviral, hematologic and dermatologic therapeutic areas. In 2012 he was the industry project leader for the design and establishment of the COMBACTE EU Clinical Trial Network for antibacterial agents funded through the Innovative Medicines Initiative public private partnership program. Dr. White was an assistant professor of medicine at the University Of Pittsburgh School Of Medicine and the Baylor College of Medicine where he led NIH-funded research into the role of hematopoietic growth factors in normal and pathologic blood cell development and function. Dr. White completed his internal medicine residency at the Hershey Medical Center and subsequent infectious diseases fellowship at the University of Pittsburgh. He has authored and co-authored several scientific papers on the topics of hematopoietic growth factors driving neoplastic transformation of blood and solid organ cells, as well as a textbook chapters regarding bacterial resistance, transplant infectious diseases and hematopoietic growth factors. Dr. White received his M.D. from the Pennsylvania State University College of Medicine and his B.S. with Honors from the Pennsylvania State University.

Research Interest

 antibacterial, antiviral, hematologic and dermatologic therapeutic